Allegiance Financial Group Advisory Services’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$279K Buy
1,289
+89
+7% +$17K 0.05% 156
2026
Q1
$220K Buy
+1,200
New +$221K 0.04% 176
2025
Q2
– Sell
-1,847
Closed -$253K – 158
2025
Q1
$253K Buy
+1,847
New +$264K 0.08% 109

Other funds holding BIIB

Allegiance Financial Group Advisory Services's BIIB Position: Q2 2026 in Review

Allegiance Financial Group Advisory Services increased its Biogen (BIIB) stake by 7.4% in Q2 2026, buying an estimated $17K and bringing the position to 1,289 shares worth $279K. The position accounts for 0.05% of the portfolio, ranked #156.

Allegiance Financial Group Advisory Services first reported a position in BIIB in Q1 2025 and has held it in 3 quarters since. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Allegiance Financial Group Advisory Services held 1,289 shares of Biogen worth $279K as of Q2 2026.
  • Allegiance Financial Group Advisory Services bought 89 Biogen shares in Q2 2026, an estimated $17K.
  • Biogen made up 0.05% of Allegiance Financial Group Advisory Services's portfolio in Q2 2026, its #156 holding.
  • Allegiance Financial Group Advisory Services first reported a position in Biogen in Q1 2025 and has held it in 3 quarters since.
  • 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Allegiance Financial Group Advisory Services's 13F filing for Q2 2026, filed 27 Jul 2026.